SS Innovations International, Inc. (NASDAQ: SSII) has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards, an honor that recognizes excellence in innovation, commercial success, industry leadership and positive societal impact. The award underscores the company's growing footprint in the surgical robotics market, driven by its SSi Mantra surgical robotic system.
According to the company, the SSi Mantra system is gaining traction for its advanced technology, user-friendly design, comprehensive training capabilities and cost efficiency. As of June 22, 2026, SS Innovations reported that 11,719 multi-specialty procedures had been performed using the system, including 612 cardiac procedures, 175 telesurgeries and 212 pediatric surgeries. The platform has been used for more than 170 procedure types and has received regulatory approval in 14 countries. Additionally, approximately 2,100 physicians have been trained on the SSi Mantra system.
The award reflects the company's mission to make robotic surgery affordable and accessible to a larger segment of the global population. SS Innovations develops innovative surgical robotic technologies, including its proprietary SSi Mantra system and a comprehensive suite of SSi Mudra surgical instruments that support a variety of procedures, including cardiac surgery. Headquartered in India but incorporated in the United States, the company plans to expand the global presence of its technologically advanced and cost-effective solutions.
For more details on the award, the full press release is available at https://ibn.fm/XWdRe. Additional information about the company and its products can be found on its website at ssinnovations.com.
